All News
Company News 2025-12-15
ZHENYIBIO Expands Plant-Derived PDRN Product Line

We are pleased to announce the expansion of our plant-derived PDRN range, now featuring extracts from rose, centella asiatica, green tea, and eight other botanical sources.
ZHENYIBIO has significantly expanded its plant-derived PDRN product portfolio, now offering nucleotide extracts from ten distinct botanical sources including Rosa damascena, Centella asiatica, Camellia sinensis, Panax ginseng, and others. This expansion responds to growing market demand for plant-based bioactive ingredients in cosmetic and food applications. Each plant-derived PDRN is produced using our proprietary extraction technology, ensuring consistent quality and bioactivity.
